Development of Blood Glucose Control for Extremely Premature Infants (2011)
Type of ContentJournal Article
PublisherUniversity of Canterbury. Mechanical Engineering
Extremely premature neonates often experience hyperglycaemia, which has been linked to increased mortality and worsened outcomes. Insulin therapy can assist in controlling blood glucose levels and promoting needed growth. This study presents the development of a model-based stochastic targeted controller designed to adapt insulin infusion rates to match the unique and changing metabolic state and control parameters of the neonate. Long-term usage of targeted BG control requires successfully forecasting variations in neonatal metabolic state, accounting for differences in clinical practices between units, and demonstrating robustness to errors that can occur in everyday clinical usage. Simulation studies were used to evaluate controller ability to target several common BG ranges and evaluate controller sensitivity to missed BG measurements and delays in control interventions on a virtual patient cohort of 25 infants developed from retrospective data. Initial clinical pilot trials indicated model performance matched expected performance from simulations. Stochastic targeted glucose control developed using validated patient-specific virtual trials can yield effective protocols for this cohort. Long-term trials show fundamental success, however clinical interface design appears as a critical factor to ensuring good compliance and thus good control.
CitationLeCompte, A.J., Chase, J.G., Lynn, A., Hann, C.E., Shaw, G.M., Lin, J. (2011) Development of Blood Glucose Control for Extremely Premature Infants. Computer Methods and Programs in Biomedicine, 102(2), pp. 181-191.
This citation is automatically generated and may be unreliable. Use as a guide only.
KeywordsGlucose; simulation; insulin; control; real-time; neonate; user interface.
ANZSRC Fields of Research32 - Biomedical and clinical sciences::3202 - Clinical sciences::320212 - Intensive care
32 - Biomedical and clinical sciences::3202 - Clinical sciences::320208 - Endocrinology
32 - Biomedical and clinical sciences::3201 - Cardiovascular medicine and haematology::320102 - Haematology
40 - Engineering::4003 - Biomedical engineering::400303 - Biomechanical engineering
Showing items related by title, author, creator and subject.
Lin, J.; Razak, N.N.; Pretty, C.G.; LeCompte, A.J.; Docherty, P.D.; Parente, J.D.; Shaw, Geoff; Hann, C.E.; Chase, Geoff (University of Canterbury. Electrical and Computer EngineeringUniversity of Canterbury. Mathematics and StatisticsUniversity of Canterbury. Mechanical Engineering, 2010)A comprehensive, more physiologically relevant Intensive Control Insulin-Nutrition- Glucose (ICING) Model is presented and validated using data from critically ill patients. Glucose utilisation and its endogenous production ...
Virtual Patients and Clinical Trial Simulations to Improve Safety of Glucose Control in Intensive Care Fisk, L.; Le Compte, A.J.; Shaw, Geoff; Chase, Geoff (University of Canterbury. Mechanical Engineering, 2012)Despite the potential clinical benefits of normalizing blood glucose in critically ill patients, the risk of hypoglycemia is a major barrier to widespread clinical adoption of accurate glycemic control. To compare five ...
Interface design and human factors considerations for model-based tight glycemic control in critical care Ward, L.; Steel., J; LeCompte, A.J.; Evans, A.; Tan, C-S.; Penning, S.; Shaw, Geoff; Desaive, T.; Chase, Geoff (University of Canterbury. Mechanical Engineering, 2012)Introduction: Tight glycemic control (TGC) has shown benefits but has been difficult to implement. Model-based methods and computerized protocols offer the opportunity to improve TGC quality and compliance. This research ...